An medicament for preventive and/or therapeutic treatment of a disease caused by mitochondrial functional abnormality, or a disease with mitochondrial functional abnormality, e.g., ischemic diseases, toxic diseases, degenerative diseases, which comprises as an active ingredient a substance having a stabilizing effect on mitochondrial membrane by stabilizing mitochondrial membrane potential, e.g., 2-oxo-1-pyrrolidinylacetic acid 2,6-dimethylanilide which acts as a benzodiazepine receptor antagonist.
一种用于预防和/或治疗由线粒体功能异常引起的疾病或线粒体功能异常疾病(如缺血性疾病、中毒性疾病、退行性疾病)的药物,其活性成分包括通过稳定线粒体膜电位对线粒体膜具有稳定作用的物质,如线粒体膜电位稳定剂、 一种用于预防和/或治疗由线粒体功能异常引起的疾病或具有线粒体功能异常的疾病(如缺血性疾病、中毒性疾病、退行性疾病)的药物,其有效成分包括通过稳定线粒体膜电位对线粒体膜具有稳定作用的物质,如作为
苯并二氮杂卓受体拮抗剂的 2-氧代-1-
吡咯烷基
乙酸 2,6-二甲基苯胺。